Search

Thuy V Tran

Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )

Most Active Art Unit
2821
Art Unit(s)
2821, 2844, 2856, 2814
Total Applications
2202
Issued Applications
1909
Pending Applications
47
Abandoned Applications
246

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18128838 [patent_doc_number] => 11555037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-17 [patent_title] => Purine diones as Wnt pathway modulators [patent_app_type] => utility [patent_app_number] => 17/100474 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 21631 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100474 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/100474
Purine diones as Wnt pathway modulators Nov 19, 2020 Issued
Array ( [id] => 17156383 [patent_doc_number] => 20210317434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => SMALL-MOLECULE MEDIATED SIZE SELECTION OF NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 16/953857 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953857 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/953857
Small-molecule mediated size selection of nucleic acids Nov 19, 2020 Issued
Array ( [id] => 18071413 [patent_doc_number] => 11530236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-20 [patent_title] => CD73 inhibitors [patent_app_type] => utility [patent_app_number] => 17/083871 [patent_app_country] => US [patent_app_date] => 2020-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27659 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083871 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/083871
CD73 inhibitors Oct 28, 2020 Issued
Array ( [id] => 16824222 [patent_doc_number] => 20210139515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => Preparation of Organosilicon Compound Having (Meth)acryloyloxy Group [patent_app_type] => utility [patent_app_number] => 17/077263 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077263 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/077263
Preparation of organosilicon compound having (meth)acryloyloxy group Oct 21, 2020 Issued
Array ( [id] => 16778443 [patent_doc_number] => 20210115521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => METHOD FOR INHIBITING TUMOR PROGRESSION OR DETERMINING TUMOR PROGRESSION STATE IN GASTRIC CANCER [patent_app_type] => utility [patent_app_number] => 17/074647 [patent_app_country] => US [patent_app_date] => 2020-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074647 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/074647
METHOD FOR INHIBITING TUMOR PROGRESSION OR DETERMINING TUMOR PROGRESSION STATE IN GASTRIC CANCER Oct 19, 2020 Abandoned
Array ( [id] => 17922807 [patent_doc_number] => 11466040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Methods of making metal halide perovskites [patent_app_type] => utility [patent_app_number] => 17/075280 [patent_app_country] => US [patent_app_date] => 2020-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 27 [patent_no_of_words] => 9856 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075280 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/075280
Methods of making metal halide perovskites Oct 19, 2020 Issued
Array ( [id] => 16839373 [patent_doc_number] => 20210147385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS [patent_app_type] => utility [patent_app_number] => 17/072844 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072844 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/072844
Compounds and methods for targeting pathogenic blood vessels Oct 15, 2020 Issued
17/060602 COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION Sep 30, 2020 Abandoned
Array ( [id] => 16710278 [patent_doc_number] => 20210077425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => AFFINITY MEDICANT CONJUGATE [patent_app_type] => utility [patent_app_number] => 17/035529 [patent_app_country] => US [patent_app_date] => 2020-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035529 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/035529
Affinity medicant conjugates Sep 27, 2020 Issued
Array ( [id] => 16570611 [patent_doc_number] => 20210009617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/032267 [patent_app_country] => US [patent_app_date] => 2020-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032267 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/032267
Compositions and methods comprising conductive metal organic frameworks and uses thereof Sep 24, 2020 Issued
Array ( [id] => 16570614 [patent_doc_number] => 20210009620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY [patent_app_type] => utility [patent_app_number] => 17/028109 [patent_app_country] => US [patent_app_date] => 2020-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028109 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/028109
PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY Sep 21, 2020 Abandoned
Array ( [id] => 17913169 [patent_doc_number] => 20220315564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION [patent_app_type] => utility [patent_app_number] => 17/028720 [patent_app_country] => US [patent_app_date] => 2020-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 149493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028720 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/028720
Methods and compounds for restoring mutant p53 function Sep 21, 2020 Issued
Array ( [id] => 16555701 [patent_doc_number] => 20210000849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => SYNTHETIC COMPOSITION AND METHOD FOR MODULATING EMOTION AND MOOD DISORDERS [patent_app_type] => utility [patent_app_number] => 17/026616 [patent_app_country] => US [patent_app_date] => 2020-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026616 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/026616
Synthetic composition and method for modulating emotion and mood disorders Sep 20, 2020 Issued
Array ( [id] => 17571079 [patent_doc_number] => 11319337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-03 [patent_title] => 3-desoxy derivative and pharmaceutical compositions thereof [patent_app_type] => utility [patent_app_number] => 17/025475 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10801 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025475 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/025475
3-desoxy derivative and pharmaceutical compositions thereof Sep 17, 2020 Issued
Array ( [id] => 16726575 [patent_doc_number] => 20210093722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => CYANOBACTERIUM EXTRACELLULAR POLYMER, COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/019991 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019991 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/019991
Cyanobacterium extracellular polymer, compositions and uses thereof Sep 13, 2020 Issued
Array ( [id] => 16540815 [patent_doc_number] => 20200407228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => PREPARATION OF SI-H CONTAINING IODOSILANES VIA HALIDE EXCHANGE REACTION [patent_app_type] => utility [patent_app_number] => 17/017193 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017193 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/017193
PREPARATION OF SI-H CONTAINING IODOSILANES VIA HALIDE EXCHANGE REACTION Sep 9, 2020 Pending
Array ( [id] => 16523646 [patent_doc_number] => 20200397726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 17/013352 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013352 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/013352
DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS Sep 3, 2020 Abandoned
Array ( [id] => 16525214 [patent_doc_number] => 20200399294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => PROCESS FOR THE PRODUCTION OF ALKYLTIN HALIDES [patent_app_type] => utility [patent_app_number] => 17/012090 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4231 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012090 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012090
PROCESS FOR THE PRODUCTION OF ALKYLTIN HALIDES Sep 3, 2020 Pending
Array ( [id] => 16512885 [patent_doc_number] => 20200392143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/006072 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 2123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006072 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/006072
Heterocyclic compounds as LSD1 inhibitors Aug 27, 2020 Issued
Array ( [id] => 16656003 [patent_doc_number] => 20210052639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS [patent_app_type] => utility [patent_app_number] => 16/997648 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997648 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/997648
COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS Aug 18, 2020 Pending
Menu